Resveratrol supplementation: Where are we now and where should we go?

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 25625901)

Published in Ageing Res Rev on January 24, 2015

Authors

Marta G Novelle1, Devin Wahl2, Carlos Diéguez3, Michel Bernier2, Rafael de Cabo4

Author Affiliations

1: Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD 21224, USA; Research Center of Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela 15706, Spain.
2: Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
3: Research Center of Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela 15706, Spain.
4: Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD 21224, USA. Electronic address: decabora@grc.nia.nih.gov.

Associated clinical trials:

A Nutrient Cocktail to Protect Against Physical Inactivity | NCT03313869

Articles citing this

Neurohormetic phytochemicals: An evolutionary-bioenergetic perspective. Neurochem Int (2015) 0.83

Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice. Trends Neurosci (2016) 0.81

Caloric restriction and exercise "mimetics'': Ready for prime time? Pharmacol Res (2015) 0.81

Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. J Exp Clin Cancer Res (2017) 0.80

Critical review of resveratrol in xenobiotic-induced hepatotoxicity. Food Chem Toxicol (2015) 0.80

Natural Compounds Modulating Mitochondrial Functions. Evid Based Complement Alternat Med (2015) 0.79

Resveratrol supplementation confers neuroprotection in cortical brain tissue of nonhuman primates fed a high-fat/sucrose diet. Aging (Albany NY) (2016) 0.78

Metformin and Resveratrol Inhibited High Glucose-Induced Metabolic Memory of Endothelial Senescence through SIRT1/p300/p53/p21 Pathway. PLoS One (2015) 0.78

Resveratrol suppresses myofibroblast activity of human buccal mucosal fibroblasts through the epigenetic inhibition of ZEB1 expression. Oncotarget (2016) 0.78

Targeting reactive oxygen species in development and progression of pancreatic cancer. Expert Rev Anticancer Ther (2016) 0.77

(Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression. Cancer Res (2016) 0.76

Pharmacological Strategies to Retard Cardiovascular Aging. Circ Res (2016) 0.76

Nutritional strategies to optimise cognitive function in the aging brain. Ageing Res Rev (2016) 0.76

The synergistic effect of resveratrol in combination with cisplatin on apoptosis via modulating autophagy in A549 cells. Acta Biochim Biophys Sin (Shanghai) (2016) 0.76

Mitochondrial health, the epigenome and healthspan. Clin Sci (Lond) (2016) 0.76

Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity. Oxid Med Cell Longev (2016) 0.75

New Insights on the Use of Dietary Polyphenols or Probiotics for the Management of Arterial Hypertension. Front Physiol (2016) 0.75

Resveratrol mediates cell cycle arrest and cell death in human esophageal squamous cell carcinoma by directly targeting the EGFR signaling pathway. Oncol Lett (2016) 0.75

At the interface of antioxidant signalling and cellular function: Key polyphenol effects. Mol Nutr Food Res (2016) 0.75

Prevention of obesity by dietary resveratrol: how strong is the evidence? Expert Rev Endocrinol Metab (2015) 0.75

Plant-Derived Agents for Counteracting Cisplatin-Induced Nephrotoxicity. Oxid Med Cell Longev (2016) 0.75

Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion. PLoS One (2016) 0.75

Resveratrol preferentially inhibits IgE-dependent PGD2 biosynthesis but enhances TNF production from human skin mast cells. Biochim Biophys Acta (2016) 0.75

During yeast chronological aging resveratrol supplementation results in a short-lived phenotype Sir2-dependent. Redox Biol (2017) 0.75

Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway. J Exp Clin Cancer Res (2017) 0.75

The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications. Diseases (2016) 0.75

Resveratrol enhances polyubiquitination-mediated ARV7 degradation in prostate cancer cells. Oncotarget (2017) 0.75